foxo4 dri senolytic or senomorphic Development of a novel by precise disruption of FOXO4-p53 complex Molecular modelling of the FOXO4-TP53

Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Senolytics & Cellular Senescence Explained Why I'm Waiting on FOXO4 DRI YouTube Targeting cellular senescence with senotherapeutics: senolytics and senomorphics Zhang 2023 The FEBS Journal Wiley Online Library Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect The FOXO4 peptide in a DRI conformation (D amino acids in a retro reversed sequence), henceforth named FOXO4 DRI, competes with FOXO4 for p53 binding in a dose dependent manner and doing so with higher affinity. Senolytics: charting a new course or enhancing existing anti tumor therapies? Cellular Oncology Springer Nature Link

SKU: 71078283976 · From southroadsurgery.com.au